1. Home
  2. NEON vs MIRA Comparison

NEON vs MIRA Comparison

Compare NEON & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neonode Inc.

NEON

Neonode Inc.

HOLD

Current Price

$1.90

Market Cap

32.1M

Sector

Technology

ML Signal

HOLD

Logo MIRA Pharmaceuticals Inc.

MIRA

MIRA Pharmaceuticals Inc.

HOLD

Current Price

$1.49

Market Cap

33.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NEON
MIRA
Founded
1997
2020
Country
Sweden
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
32.1M
33.7M
IPO Year
2007
2023

Fundamental Metrics

Financial Performance
Metric
NEON
MIRA
Price
$1.90
$1.49
Analyst Decision
Hold
Analyst Count
1
0
Target Price
$6.00
N/A
AVG Volume (30 Days)
212.9K
226.9K
Earning Date
11-06-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.54
N/A
Revenue
$2,197,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$43.34
N/A
P/E Ratio
$3.64
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.72
$0.73
52 Week High
$29.90
$2.45

Technical Indicators

Market Signals
Indicator
NEON
MIRA
Relative Strength Index (RSI) 37.42 50.10
Support Level $1.85 $1.45
Resistance Level $1.96 $1.54
Average True Range (ATR) 0.09 0.05
MACD 0.03 -0.01
Stochastic Oscillator 46.97 33.33

Price Performance

Historical Comparison
NEON
MIRA

About NEON Neonode Inc.

Neonode Inc provides optical sensing solutions for contactless touch, and gesture sensing and also provides software solutions for machine perception that feature machine learning algorithms to detect and track persons and objects in video streams from cameras and other types of imagers. It markets and sells its solutions to customers in many different markets and segments including, office equipment, automotive, industrial automation, medical, military, and avionics. The company geographically operates in the United States, Japan, South Korea, Germany, Sweden, China, and other regions. A majority of its revenue is generated from Japan.

About MIRA MIRA Pharmaceuticals Inc.

Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.

Share on Social Networks: